创伤性脑损伤患者生命维持措施撤除的发生与时机:CENTER-TBI 研究
CENTER-TBI 为前瞻性多中心队列研究,纳入 2022 例≥16 岁入住 ICU 的 TBI 患者,ICU 死亡率 13%(267 例),其中 229 例(86%)死于撤除生命维持措施(WLSM)后。WLSM 发生率地区差异极大(东欧 0% 至北欧 96%)。51% 的 WLSM 为早期(<72 h),早期组最大治疗强度评分更低(中位 5 vs 10)。与早期 WLSM 最强相关的独立因素为单侧瞳孔无反应(OR 4.0,95%CI 1.3-12.4)、双侧瞳孔无反应(OR 5.8,95%CI 2.6-13.1)及 ISS>41(每增加 1 分 OR 1.1,95%CI 1.0-1.1);时机与地区或中心无显著关联。
要点
- TBI 患者 ICU 死亡中 86%(229/267)发生在 WLSM 后,提示 WLSM 是 ICU 死亡的主要前置决策。
- WLSM 时机以伤后 72 h 为界二分,51% 为早期(<72 h),早期组最大 TIL 评分中位 5,低于晚期组的 10。
- 双侧瞳孔无反应者早期 WLSM 的 OR 为 5.8(95%CI 2.6-13.1),单侧无反应 OR 4.0(95%CI 1.3-12.4),均以双侧有反应为参照。
- ISS>41 时每增加 1 分早期 WLSM 的 OR 为 1.1(95%CI 1.0-1.1)。
- WLSM 发生率地区间从 0% 到 96% 不等,但时机与地区或中心无显著关联。
适用人群与场景
- CENTER-TBI 研究中≥16 岁、因创伤性脑损伤入住 ICU 的患者(共 2022 例)。
- 分析对象为 ICU 死亡且死于 WLSM 后的 229 例患者。
诊断标准与关键阈值
- WLSM 时机以伤后 72 h 为界二分:早期为<72 h,后期为≥72 h,依据为近期指南推荐。
- 最大治疗强度水平(TIL)评分用于描述治疗强度,早期组中位 5、后期组中位 10。
- 格拉斯哥昏迷评分、瞳孔反应、ISS 等作为与 WLSM 时机相关的评估变量。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 单侧瞳孔无反应(OR 4.0,95%CI 1.3-12.4)或双侧瞳孔无反应(OR 5.8,95%CI 2.6-13.1)与早期 WLSM 独立相关,提示脑干反射消失者需审慎评估预后。
- ISS>41 每增加 1 分早期 WLSM 的 OR 为 1.1(95%CI 1.0-1.1),严重多发伤患者早期 WLSM 风险升高。
- 作者指出 WLSM 可能构成自我实现的预言,任何对预后存疑时不应过早实施 WLSM。
研究设计与关键结果
- 研究类型:前瞻性多中心队列研究(CENTER-TBI);样本量 2022 例≥16 岁 ICU 的 TBI 患者。
- ICU 死亡率 13%(267 例),其中 229 例(86%)死于 WLSM 后并纳入分析。
- WLSM 发生率地区差异大:东欧 0% 至北欧 96%;51% 的患者 WLSM 为早期(<72 h)。
- 早期 WLSM 组最大 TIL 评分中位 5,后期组中位 10。
- 多因素分析:单侧瞳孔无反应 OR 4.0(95%CI 1.3-12.4)、双侧无反应 OR 5.8(95%CI 2.6-13.1)、ISS>41 每分 OR 1.1(95%CI 1.0-1.1)与早期 WLSM 独立相关;时机与地区或中心无显著关联。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究(观察性设计)。
- 局限:WLSM 时机与预后因素的关联可能受自我实现预言影响;原文未报告各中心 WLSM 决策标准;地区差异大提示实践异质性。
对床旁实践的改变
- 对重度 TBI 尤其脑干反射消失、ISS>41 者,早期 WLSM 决策需谨慎,原文强调任何预后存疑时不应过早实施 WLSM。
- WLSM 时机与地区或中心无关,提示决策应基于患者因素而非机构惯例;但原文为观察性研究,不能据此确立因果或统一阈值。
- 原文未提及具体药物剂量或处置流程,不能从本文推出 WLSM 的具体操作方案。
指南或共识出处
- CENTER-TBI 研究(Intensive Care Med)
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with severe brain injury, withdrawal of life-sustaining measures (WLSM) is common in intensive care units (ICU). WLSM constitutes a dilemma: instituting WLSM too early could result in death despite the possibility of an acceptable functional outcome, whereas delaying WLSM could unnecessarily burden patients, families, clinicians, and hospital resources. We aimed to describe the occurrence and timing of WLSM, and factors associated with timing of WLSM in European ICUs in patients with traumatic brain injury (TBI).
METHODS: The CENTER-TBI Study is a prospective multi-center cohort study. For the current study, patients with traumatic brain injury (TBI) admitted to the ICU and aged 16 or older were included. Occurrence and timing of WLSM were documented. For the analyses, we dichotomized timing of WLSM in early (< 72 h after injury) versus later (≥ 72 h after injury) based on recent guideline recommendations. We assessed factors associated with initiating WLSM early versus later, including geographic region, center, patient, injury, and treatment characteristics with univariable and multivariable (mixed effects) logistic regression.
RESULTS: A total of 2022 patients aged 16 or older were admitted to the ICU. ICU mortality was 13% (n = 267). Of these, 229 (86%) patients died after WLSM, and were included in the analyses. The occurrence of WLSM varied between regions ranging from 0% in Eastern Europe to 96% in Northern Europe. In 51% of the patients, WLSM was early. Patients in the early WLSM group had a lower maximum therapy intensity level (TIL) score than patients in the later WLSM group (median of 5 versus 10) The strongest independent variables associated with early WLSM were one unreactive pupil (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.3-12.4) or two unreactive pupils (OR 5.8, CI 2.6-13.1) compared to two reactive pupils, and an Injury Severity Score (ISS) if over 41 (OR per point above 41 = 1.1, CI 1.0-1.1). Timing of WLSM was not significantly associated with region or center.
CONCLUSION: WLSM occurs early in half of the patients, mostly in patients with severe TBI affecting brainstem reflexes who were severely injured. We found no regional or center influences in timing of WLSM. Whether WLSM is always appropriate or may contribute to a self-fulfilling prophecy requires further research and argues for reluctance to institute WLSM early in case of any doubt on prognosis.
参考来源
- van Veen E, van der Jagt M, Citerio G, et al. Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI study. Intensive Care Med. 2021. PMID: 34351445. doi:10.1007/s00134-021-06484-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。